Manuscripts from 2017
Diversity and plasticity in signaling pathways that regulate smooth muscle responsiveness: Paradigms and paradoxes for the myosin phosphatase, the master regulator of smooth muscle contraction., Masumi Eto and Toshio Kitazawa
Unfair competition governs the interaction of pCPI-17 with myosin phosphatase (PP1-MYPT1)., Joshua J. Filter, Byron C. Williams, Masumi Eto, David Shalloway, and Michael L. Goldberg
Submissions from 2014
Arterial stiffness and wave reflection 1 year after a pregnancy complicated by hypertension., Deborah B Ehrenthal, Neal D Goldstein, Pan Wu, Stephanie Rogers, Raymond R Townsend, and David G Edwards
Permeation Redux: Thermodynamics and Kinetics of Ion Movement through Potassium Channels., Richard Horn, Benoît Roux, and Johan Aqvist
Manuscripts from 2013
Nuclear localization of CPI-17, a protein phosphatase-1 inhibitor protein, affects histone H3 phosphorylation and corresponds to proliferation of cancer and smooth muscle cells., Masumi Eto, Jason A Kirkbride, Rishika Chugh, Nana Kofi Karikari, and Jee In Kim
Manuscripts from 2012
Endogenous inhibitor proteins that connect Ser/Thr kinases and phosphatases in cell signaling., Masumi Eto and David L Brautigan
Neurophysiological Impact and Modeling-independent elucidation of inactivation pathways in A-type K+ channels, J.D. Fineberg, David Ritter, and Manuel Covarrubias
Identification of the functional binding pocket for compounds targeting small-conductance Ca²⁺-activated potassium channels., Miao Zhang, John M Pascal, Marcel Schumann, Roger S Armen, and Ji-Fang Zhang
Manuscripts from 2010
Mechanism of catch force: tethering of thick and thin filaments by twitchin., Thomas M Butler and Marion J Siegman
Manuscripts from 2009
Y27632, a Rho-activated kinase inhibitor, normalizes dysregulation in alpha1-adrenergic receptor-induced contraction of Lyon hypertensive rat artery smooth muscle., Maria Regina Freitas, Masumi Eto, Jason A Kirkbride, Christa Schott, Jean Sassard, and Jean-Claude Stoclet
Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation., Jee In Kim, Garbo D Young, Li Jin, Avril V Somlyo, and Masumi Eto
Solution structure of the inhibitory phosphorylation domain of myosin phosphatase targeting subunit 1., Shunsuke Mori, Ryou Iwaoka, Masumi Eto, and Shin-ya Ohki
Submissions from 2008
uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer., Wenyi Qin, Weizhu Zhu, John E Hewett, George Rottinghaus, Yin-Chieh Chen, John T Flynn, Beth Kliethermes, Ferdinando Mannello, and Edward R Sauter
Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women, Edward R. Sauter, Wenyi Qin, John E. Hewett, Rachel L. Ruhlen, John T. Flynn, George Rottinghaus, and Yin-Chieh Chen
Manuscripts from 2007
Association of the tensin N-terminal protein-tyrosine phosphatase domain with the alpha isoform of protein phosphatase-1 in focal adhesions, Masumi Eto, Jason Kirkbride, Elizabeth Elliott, Su Hao Lo, and David L. Brautigan
Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor, Masumi Eto, Toshio Kitazawa, Fumiko Matsuzawa, Sei-ichi Aikawa, Jason A. Kirkbride, Noriyoshi Isozumi, Yumi Nishimura, David L. Brautigan, and Shin-ya Ohki
Manuscripts from 2006
Gαq and its Aktions, David M. Harris, Andrea D. Eckhart, and Walter J. Koch
Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer, Edward R. Sauter, Wenyi Quin, Lisa Schlatter, John E. Hewett, and John T. Flynn
Submissions from 1999
Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusion., R Scalia, V E Armstead, A G Minchenko, and A M Lefer
